Literature DB >> 33520214

Hajdu Cheney Syndrome due to NOTCH2 defect - First case report from Pakistan and review of literature.

Sibtain Ahmed1, Aahan Arif2, Saadia Abbas2, Muhammad Osama Khan2, Salman Kirmani3, Aysha Habib Khan1.   

Abstract

INTRODUCTION AND IMPORTANCE: Hajdu Cheney Syndrome (HCS) is a rare skeletal disease characterized by severe, progressive focal bone loss with osteoporosis, variable craniofacial, vertebral anomalies and distinctive facial features. It is inherited as an autosomal dominant disease although sporadic cases have been described in literature. Identifying these cases in clinical practice is important for proper diagnosis and management. CASE
PRESENTATION: We report a case of a 36-year-old male patient presented at metabolic bone disease clinic at the Aga Khan University Hospital with history of multiple fragility fractures and juvenile osteoporosis since childhood. DNA sequence analysis of the NOTCH2 coding sequence revealed a pathogenic variant in NOTCH 2, Exon 34, c.6426_6427insTT (p.Glu2143Leufs*5), consistent with a NOTCH2 related conditions including HCS. CLINICAL DISCUSSION: The multitude of presentations associated with HCS are linked to the NOTCH2 gene, as Notch signaling is one of the core signaling pathways that control embryonic development. Hence, mutations in the Notch signaling pathway cause developmental phenotypes that affect various organs including the liver, skeleton, heart, eye, face, kidney, and vasculature.
CONCLUSION: To the best of our knowledge, nucleotide mutations of c.6933delT, c.6854delA, c.6787C.T, and c.6424-6427delTCTG were all determined to be novel, with c.6428T > C being the most common mutation found in literature. The c.6426_6427insTT mutation our patient was found to have via gene sequencing too appears to be a novel mutation, which has not previously been reported in literature.
© 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.

Entities:  

Keywords:  Case report; Hajdu cheney syndrome; NOTCH2, Pakistan

Year:  2021        PMID: 33520214      PMCID: PMC7820303          DOI: 10.1016/j.amsu.2021.01.041

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  30 in total

1.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

2.  Mutations in NOTCH2 in families with Hajdu-Cheney syndrome.

Authors:  Jacek Majewski; Jeremy A Schwartzentruber; Aurore Caqueret; Lysanne Patry; Janet Marcadier; Jean-Pierre Fryns; Kym M Boycott; Louis-Georges Ste-Marie; Fergus E McKiernan; Ivo Marik; Hilde Van Esch; Jacques L Michaud; Mark E Samuels
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

3.  The cautionary tale of side effects of chronic Notch1 inhibition.

Authors:  Sandra W Ryeom
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

4.  Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.

Authors:  Michael A Simpson; Melita D Irving; Esra Asilmaz; Mary J Gray; Dimitra Dafou; Frances V Elmslie; Sahar Mansour; Sue E Holder; Caroline E Brain; Barbara K Burton; Katherine H Kim; Richard M Pauli; Salim Aftimos; Helen Stewart; Chong Ae Kim; Muriel Holder-Espinasse; Stephen P Robertson; William M Drake; Richard C Trembath
Journal:  Nat Genet       Date:  2011-03-06       Impact factor: 38.330

5.  A novel NOTCH2 mutation identified in a Korean family with Hajdu-Cheney syndrome showing phenotypic diversity.

Authors:  Mi Seon Han; Jung Min Ko; Tae-Joon Cho; Woong-Yang Park; Hae Il Cheong
Journal:  Ann Clin Lab Sci       Date:  2015       Impact factor: 1.256

Review 6.  Hajdu--Cheney syndrome: evolution of phenotype and clinical problems.

Authors:  A M Brennan; R M Pauli
Journal:  Am J Med Genet       Date:  2001-05-15

7.  Direct inhibition of the NOTCH transcription factor complex.

Authors:  Raymond E Moellering; Melanie Cornejo; Tina N Davis; Cristina Del Bianco; Jon C Aster; Stephen C Blacklow; Andrew L Kung; D Gary Gilliland; Gregory L Verdine; James E Bradner
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

8.  Clinical consequences in truncating mutations in exon 34 of NOTCH2: report of six patients with Hajdu-Cheney syndrome and a patient with serpentine fibula polycystic kidney syndrome.

Authors:  Yoko Narumi; Byung-Joo Min; Kenji Shimizu; Itsuro Kazukawa; Kiyoko Sameshima; Koichi Nakamura; Tomoki Kosho; Yumie Rhee; Yoon-Sok Chung; Ok-Hwa Kim; Yoshimitsu Fukushima; Woong-Yang Park; Gen Nishimura
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

9.  Hajdu Cheney Syndrome.

Authors:  Shini Susan Samuel; Shrinath Shetty; Gautham Arunachal; Santosh Koshy; Thomas Vizhalil Paul
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 10.  Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.

Authors:  James F H Pittaway; Christopher Harrison; Yumie Rhee; Muriel Holder-Espinasse; Alan E Fryer; Tim Cundy; William M Drake; Melita D Irving
Journal:  Orphanet J Rare Dis       Date:  2018-04-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.